GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NeuroMetrix Inc (NAS:NURO) » Definitions » Shiller PE Ratio

NeuroMetrix (NeuroMetrix) Shiller PE Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is NeuroMetrix Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


NeuroMetrix Shiller PE Ratio Historical Data

The historical data trend for NeuroMetrix's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuroMetrix Shiller PE Ratio Chart

NeuroMetrix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NeuroMetrix Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NeuroMetrix's Shiller PE Ratio

For the Medical Devices subindustry, NeuroMetrix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeuroMetrix's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroMetrix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NeuroMetrix's Shiller PE Ratio falls into.



NeuroMetrix Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NeuroMetrix's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, NeuroMetrix's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.082/129.4194*129.4194
=-1.082

Current CPI (Dec. 2023) = 129.4194.

NeuroMetrix Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -537.600 99.695 -697.891
201406 -2,176.000 100.560 -2,800.497
201409 -486.400 100.428 -626.814
201412 -921.600 99.070 -1,203.929
201503 -640.000 99.621 -831.434
201506 -1,324.800 100.684 -1,702.902
201509 -678.400 100.392 -874.557
201512 -428.457 99.792 -555.660
201603 -640.000 100.470 -824.406
201606 -3,438.400 101.688 -4,376.084
201609 -488.800 101.861 -621.044
201612 -332.800 101.863 -422.832
201703 -581.600 102.862 -731.759
201706 -199.200 103.349 -249.449
201709 -248.800 104.136 -309.208
201712 -85.146 104.011 -105.946
201803 6.400 105.290 7.867
201806 3.200 106.317 3.895
201809 6.400 106.507 7.777
201812 -30.379 105.998 -37.092
201903 11.760 107.251 14.191
201906 -29.760 108.070 -35.639
201909 -11.520 108.329 -13.763
201912 -6.036 108.420 -7.205
202003 -3.600 108.902 -4.278
202006 -2.240 108.767 -2.665
202009 -0.560 109.815 -0.660
202012 -0.687 109.897 -0.809
202103 -0.160 111.754 -0.185
202106 -1.040 114.631 -1.174
202109 -0.960 115.734 -1.074
202112 -1.201 117.630 -1.321
202203 -1.120 121.301 -1.195
202206 -1.360 125.017 -1.408
202209 -1.840 125.227 -1.902
202212 -0.711 125.222 -0.735
202303 -1.600 127.348 -1.626
202306 -1.520 128.729 -1.528
202309 -1.680 129.860 -1.674
202312 -1.082 129.419 -1.082

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NeuroMetrix  (NAS:NURO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


NeuroMetrix Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of NeuroMetrix's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NeuroMetrix (NeuroMetrix) Business Description

Traded in Other Exchanges
N/A
Address
4B Gill Street, Woburn, MA, USA, 01801
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
Executives
Bradley M Fluegel director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Thomas T Higgins officer: Chief Financial Officer
Topline Capital Management, Llc other: See Explanation in Footnotes 544 EUCLID STREET, SANTA MONICA CA 90402
Topline Capital Partners, Lp 10 percent owner 544 EUCLID STREET, SANTA MONICA CA 90402
Mcbirney Collin other: See Explanation in Footnotes 544 EUCLID STREET, SANTA MONICA CA 90402
Shai Gozani director, officer: Chairman, President and CEO C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM MA 02451
Francis X Mcgillin officer: Senior VP, Consumer C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM MA 02451
Avermaete David Van director C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM MA 02451
Krishnamurthy Balachandran officer: S. VP and GM, International C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM MA 02451
Nancy E Katz director CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
Neurometrix Inc officer: Senior Vice President & GM
Walter Christensen officer: Sr. VP, Global Sales C/O NEUROMETRIX, INC., 62 FOURTH AVENUE, WALTHAM MA 02451
Timothy R Surgenor director 100 FOXBOROUGH BOULEVARD, SUITE 240, FOXBOROUGH MA 02035
Deerfield Management Company, L.p. (series C) 10 percent owner 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017